TEVA PHARMACEUTICALS INTERNATIONAL GMBH;SMITH Mark Alan;CLAASSEN-PUNT Carine
发明人:
SMITH Mark Alan,CLAASSEN-PUNT Carine
申请号:
IL25808618
公开号:
IL258086D0
申请日:
2018.03.13
申请国别(地区):
IL
年份:
2018
代理人:
摘要:
The disclosure is directed to methods of treating schizophrenia or bipolar disorder by subcutaneously administering a sustained-release dosage form of olanzapine, or a pharmaceutically acceptable salt thereof. Methods of subcutaneously administering olanzapine, or a pharmaceutically acceptable salt thereof, are also described.